These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 21890451

  • 1. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J.
    Clin Cancer Res; 2011 Nov 01; 17(21):6802-11. PubMed ID: 21890451
    [Abstract] [Full Text] [Related]

  • 2. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV, Agudo-López A, Pérez C, López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A, Martínez-Villanueva M, Iglesias L, García-Carbonero R, Fresno Vara JA, Gámez-Pozo A, Palacios J, Cortés-Funes H, Paz-Ares L, Agulló-Ortuño MT.
    Carcinogenesis; 2013 May 01; 34(5):1031-8. PubMed ID: 23349018
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.
    J Clin Oncol; 2009 Apr 20; 27(12):2030-7. PubMed ID: 19273703
    [Abstract] [Full Text] [Related]

  • 4. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
    Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S, Suzuki M, Yoshino I, Seki N.
    J Hum Genet; 2012 Jan 20; 57(1):38-45. PubMed ID: 22089643
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.
    Oncol Rep; 2012 Jun 20; 27(6):1759-64. PubMed ID: 22407237
    [Abstract] [Full Text] [Related]

  • 6. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.
    J Surg Oncol; 2012 Feb 20; 105(2):175-82. PubMed ID: 21882196
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
    Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG.
    Cancer Res; 2009 Jul 15; 69(14):5776-83. PubMed ID: 19584273
    [Abstract] [Full Text] [Related]

  • 8. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, Hayashi Y, Sakamoto M, Takebayashi T, Betsuyaku T.
    Mol Med Rep; 2013 Aug 15; 8(2):456-62. PubMed ID: 23759980
    [Abstract] [Full Text] [Related]

  • 9. The role of microRNA in human lung squamous cell carcinoma.
    Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, Ma Q, Wang YJ.
    Cancer Genet Cytogenet; 2010 Jul 15; 200(2):127-33. PubMed ID: 20620595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC, Chow AS, Au JS.
    Eur J Cancer; 2009 Aug 15; 45(12):2197-206. PubMed ID: 19493678
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
    Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI.
    Clin Cancer Res; 2008 May 01; 14(9):2588-92. PubMed ID: 18451220
    [Abstract] [Full Text] [Related]

  • 14. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M, Baty F, Früh M, Droege C, Stahel RA, Betticher DC, von Moos R, Ochsenbein A, Pless M, Gautschi O, Rothschild S, Brauchli P, Klingbiel D, Zappa F, Brutsche M.
    Lung Cancer; 2014 Aug 01; 85(2):306-13. PubMed ID: 24928469
    [Abstract] [Full Text] [Related]

  • 15. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.
    Zhi F, Chen X, Wang S, Xia X, Shi Y, Guan W, Shao N, Qu H, Yang C, Zhang Y, Wang Q, Wang R, Zen K, Zhang CY, Zhang J, Yang Y.
    Eur J Cancer; 2010 Jun 01; 46(9):1640-9. PubMed ID: 20219352
    [Abstract] [Full Text] [Related]

  • 16. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
    Nymark P, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K, Kettunen E, Anttila S, Knuutila S.
    Genes Chromosomes Cancer; 2011 Aug 01; 50(8):585-97. PubMed ID: 21563230
    [Abstract] [Full Text] [Related]

  • 17. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
    Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H.
    J Clin Oncol; 2010 Apr 01; 28(10):1721-6. PubMed ID: 20194856
    [Abstract] [Full Text] [Related]

  • 18. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P, Rusch V, Talbot SG, Sarkaria I, Viale A, Socci N, Ngai I, Rao P, Singh B.
    Clin Cancer Res; 2004 Sep 01; 10(17):5792-803. PubMed ID: 15355908
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.
    Cancer Res; 2010 Jan 01; 70(1):36-45. PubMed ID: 20028859
    [Abstract] [Full Text] [Related]

  • 20. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.
    Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J, He J.
    Cancer Res; 2008 Jan 01; 68(1):26-33. PubMed ID: 18172293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.